Vivek Ramaswamy: Developing Drugs For Neglected Diseases - a podcast by Forbes

Founder and CEO of Roivant Sciences, 31-year-old Vivek Ramaswamy, goes deep into the workings of the pharmaceutical industry. He explores questions including: Why take on Alzheimers when other big pharmaceuticals aren't? Why have there been so few changes in drug development for women's health? And why he's willing to take the financial risk of investing in drug research that fails.

Further episodes of The Forbes Interview

Further podcasts by Forbes

Website of Forbes